NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
NU SKIN ENTERPRISES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$4.97−0.17 (-3.31%)
Close on Oct 19, 2026
- Market cap
- $241.52M
- P/E (TTM)
- –
- Dividend yield
- –
NU SKIN ENTERPRISES, INC. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas [Member] | $282.98M | $322.52M | $398.22M | $508.54M | $547.76M | $453.02M | $304.42M | – | – | – | 19.1% | -12.3% |
| Southeast Asia/Pacific [Member] | $209.80M | $244.85M | $267.21M | $344.41M | $336.65M | $361.63M | $346.28M | – | – | – | 14.1% | -14.3% |
| Manufacturing [Member] | $205.79M | $201.43M | $181.40M | $149.46M | $172.12M | $149.34M | $121.92M | $90.61M | $0 | – | 13.9% | +2.2% |
| Mainland China [Member] | $195.55M | $235.24M | $298.08M | $360.39M | $568.77M | $625.54M | $722.53M | $886.47M | – | – | 13.2% | -16.9% |
| Japan [Member] | $174.36M | $181.56M | $207.83M | $224.90M | $266.22M | $273.68M | $260.04M | $254.94M | – | – | 11.7% | -4.0% |
| Europe & Africa [Member] | $150.15M | $164.16M | $192.35M | $204.28M | $283.20M | – | – | – | – | – | 10.1% | -8.5% |
| South Korea [Member] | $130.22M | $163.71M | $236.10M | $268.71M | $354.25M | $326.48M | $329.98M | $373.36M | – | – | 8.8% | -20.5% |
| Hong Kong/Taiwan [Member] | $117.38M | $130.61M | $153.59M | $157.20M | $162.61M | $161.12M | $166.34M | $185.89M | – | – | 7.9% | -10.1% |
| Rhyz Other [Member] | $17.79M | $85.19M | $35.21M | $3.83M | $437.00K | $0 | $0 | – | – | – | 1.2% | -79.1% |
| Grow Tech [Member] | – | – | – | – | $2.10M | $903.00K | $137.00K | $0 | $0 | – | – | – |
| Nu Skin [Member] | – | – | – | $2.07B | $2.52B | $2.43B | $2.30B | $2.59B | – | – | – | – |
| Americas/Pacific [Member] | – | – | – | – | – | $511.94M | $349.08M | $385.03M | – | – | – | – |
| Southeast Asia [Member] | – | – | – | – | – | $302.71M | $301.62M | $316.89M | – | – | – | – |
| EMEA [Member] | – | – | – | $204.28M | $283.20M | $230.25M | $167.17M | $182.39M | – | – | – | – |
| Rhyz Investments [Member] | – | – | – | $153.29M | $172.56M | $149.34M | $122.05M | – | – | – | – | – |
| Rhyz [Member] | – | – | $216.61M | $153.29M | $172.56M | – | – | – | – | – | – | – |
| Nu Skin [Member] | – | – | $1.75B | $2.07B | $2.52B | – | – | – | – | – | – | – |
| Other [Member] | – | – | -$858.00K | $3.96M | $3.65M | $886.00K | $1.62M | $3.42M | $6.30M | – | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas [Member] | $60.49M | $67.72M | $78.94M | $97.30M | $103.07M | $86.39M | $52.14M | – | – | – | -10.7% |
| Japan [Member] | $48.97M | $50.80M | $54.08M | $51.62M | $65.17M | $68.03M | $61.08M | $56.68M | – | – | -3.6% |
| Southeast Asia/Pacific [Member] | $46.78M | $45.23M | $47.74M | $75.90M | $72.77M | $87.75M | $90.67M | – | – | – | +3.4% |
| Mainland China [Member] | $45.56M | $46.09M | $62.26M | $72.36M | $151.65M | $181.02M | $191.57M | $253.60M | – | – | -1.2% |
| South Korea [Member] | $37.46M | $50.75M | $74.09M | $78.81M | $110.33M | $100.93M | $99.89M | $107.22M | – | – | -26.2% |
| Hong Kong/Taiwan [Member] | $37.17M | $34.69M | $40.58M | $32.58M | $34.07M | $33.47M | $33.57M | $33.39M | – | – | +7.2% |
| Europe & Africa [Member] | $22.63M | $21.01M | $18.59M | $15.96M | $34.85M | – | – | – | – | – | +7.7% |
| Manufacturing [Member] | $7.81M | $1.46M | $12.32M | $3.57M | $18.35M | $21.17M | $15.69M | $7.75M | $0 | – | +435.1% |
| Rhyz Other [Member] | -$30.59M | -$45.81M | -$20.56M | -$6.18M | -$1.81M | $0 | $0 | – | – | – | -33.2% |
| Grow Tech [Member] | – | – | – | – | -$83.91M | -$22.43M | -$19.51M | -$9.23M | $0 | – | – |
| Nu Skin [Member] | – | – | – | $462.19M | $610.55M | $581.67M | $539.11M | $596.69M | – | – | – |
| Americas/Pacific [Member] | – | – | – | – | – | $91.63M | $57.09M | $52.43M | – | – | – |
| Southeast Asia [Member] | – | – | – | – | – | $75.54M | $82.46M | $78.60M | – | – | – |
| EMEA [Member] | – | – | – | $21.45M | $41.99M | $24.08M | $10.20M | $14.77M | – | – | – |
| Rhyz Investments [Member] | – | – | – | -$2.61M | $16.53M | $21.17M | -$3.82M | – | – | – | – |
| Rhyz [Member] | – | – | -$8.24M | -$2.61M | $16.53M | – | – | – | – | – | – |
| Nu Skin [Member] | – | – | $376.29M | $424.54M | $571.89M | – | – | – | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wellness [Member] | $689.06M | $757.22M | $886.09M | $992.34M | $1.06B | $922.55M | $863.13M | $921.33M | $817.23M | – | 46.4% | -9.0% |
| Beauty [Member] | $568.11M | $681.77M | $858.63M | $1.07B | $1.44B | $1.49B | $1.42B | – | – | – | 38.3% | -16.7% |
| Other [Member] | $227.98M | $293.10M | $224.41M | $163.61M | $190.46M | $167.58M | $133.81M | $97.94M | $5.48M | $6.92M | 15.4% | -22.2% |
| Pharmanex [Member] | – | – | – | – | – | – | – | $921.33M | $817.23M | $892.74M | – | – |
| Nu Skin [Member] | – | – | – | – | – | – | – | $1.66B | $1.46B | $1.31B | – | – |
| Personal Care [Member] | – | – | – | – | – | $1.49B | $1.42B | $1.66B | $1.46B | – | – | – |
| Devices and Related Consumables [Member] | – | – | – | – | $658.00M | $712.00M | $618.00M | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Japan | – | – | – | – | – | – | – | $254.94M | $256.09M | $279.04M | – | – |
| South Korea | – | – | – | – | – | – | – | $373.36M | $361.69M | $413.70M | – | – |
| China | – | – | – | – | – | – | – | $886.47M | $716.99M | $610.41M | – | – |
| Americas [Member] | – | – | – | – | – | – | – | – | $317.38M | $276.59M | – | – |
| EMEA [Member] | – | – | – | – | – | – | – | $182.39M | $160.28M | $147.32M | – | – |
| South Asia/Pacific [Member] | – | – | – | – | – | – | – | – | $299.98M | $296.76M | – | – |
| Hong Kong/Taiwan [Member] | – | – | – | – | – | – | – | $185.89M | $166.70M | $183.98M | – | – |
| Americas/Pacific [Member] | – | – | – | – | – | – | – | $385.03M | $342.43M | $298.77M | – | – |
| Southeast Asia [Member] | – | – | – | – | – | – | – | $316.89M | $268.63M | $271.90M | – | – |
| United States | – | – | – | – | – | – | – | – | $218.73M | $201.24M | – | – |
| All Others [Member] | – | – | – | – | – | – | – | – | $725.60M | $703.41M | – | – |
| Other [Member] | – | – | – | – | – | – | – | $94.03M | $6.30M | $2.68M | – | – |
From the segment and revenue-disaggregation notes of Nu Skin Enterprises's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.